<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="correction" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1108989</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2022.1108989</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Correction</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Addendum: A novel N-Arylpyridone compound alleviates the inflammatory and fibrotic reaction of silicosis by inhibiting the ASK1-p38 pathway and regulating macrophage polarization</article-title>
<alt-title alt-title-type="left-running-head">Fan et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2022.1108989">10.3389/fphar.2022.1108989</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Fan</surname>
<given-names>Mingming</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1600207/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xiao</surname>
<given-names>Huijuan</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1624199/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Song</surname>
<given-names>Dingyun</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhu</surname>
<given-names>Lili</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1535014/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Jie</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Xinran</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/617086/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wang</surname>
<given-names>Jing</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/710891/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Dai</surname>
<given-names>Huaping</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1997063/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wang</surname>
<given-names>Chen</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1517043/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Respiratory Medicine</institution>, <institution>The Second Hospital of Jilin University</institution>, <addr-line>Jilin</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>National Center for Respiratory Medicine</institution>, <institution>National Clinical Research Center for Respiratory Diseases</institution>, <institution>Department of Pulmonary and Critical Care Medicine Center of Respiratory Medicine</institution>, <institution>Chinese Academy of Medical Sciences</institution>, <institution>Peking Union Medical College</institution>, <institution>China-Japan Friendship Hospital</institution>, <institution>Capital Medical University</institution>, <institution>Institute of Respiratory Medicine</institution>, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Pulmonary and Critical Care Medicine</institution>, <institution>China-Japan Friendship School of Clinical Medicine</institution>, <institution>Peking University</institution>, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Institute of Clinical Medical Sciences</institution>, <institution>China-Japan Friendship Hospital</institution>, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>State Key Laboratory of Medical Molecular Biology</institution>, <institution>School of Basic Medicine Peking Union Medical College</institution>, <institution>Institute of Basic Medical Sciences Chinese Academy of Medical Sciences</institution>, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited and reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/617086/overview">Paola Patrignani</ext-link>, University of Studies G. d&#x27;Annunzio Chieti and Pescara, Italy</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Jing Wang, <email>wangjing@ibms.pumc.edu.cn</email>; Huaping Dai, <email>daihuaping@ccmu.edu.cn</email>; Chen Wang, <email>wangchen@pumc.edu.cn</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Inflammation Pharmacology, a section of the journal Frontiers in Pharmacology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>18</day>
<month>01</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>1108989</elocation-id>
<history>
<date date-type="received">
<day>27</day>
<month>11</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>11</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Fan, Xiao, Song, Zhu, Zhang, Zhang, Wang, Dai and Wang.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Fan, Xiao, Song, Zhu, Zhang, Zhang, Wang, Dai and Wang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="corrected-article" journal-id="Front. Pharmacol." journal-id-type="nlm-ta" xlink:href="10.3389/fphar.2022.848435" ext-link-type="doi">An Addendum on <article-title>A Novel N-Arylpyridone compound alleviates the inflammatory and fibrotic reaction of silicosis by inhibiting the ASK1-p38 pathway and regulating macrophage polarization</article-title> by Fan M, Xiao H, Song D, Zhu L, Zhang J, Zhang X, Wang J, Dai H and Wang C (2022). Front. Pharmacol. 13:848435. doi: <object-id>10.3389/fphar.2022.848435</object-id>
</related-article>
<kwd-group>
<kwd>AKEX0011</kwd>
<kwd>macrophage polarization</kwd>
<kwd>pirfenidone</kwd>
<kwd>pulmonary fibrosis</kwd>
<kwd>silicosis</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Missing information</title>
<p>Add information about chemical formula, <xref ref-type="table" rid="T2">Table 2</xref>, polarization and antibody list.</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>(Antibody list) Primary antibodies for Western Blot.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Antibodies</th>
<th align="left">Cat No.</th>
<th align="left">Manufacturer</th>
<th align="left">Sources of species</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Fibronectin</td>
<td align="left">ab2413</td>
<td align="left">abcam</td>
<td align="left">Rabbit</td>
</tr>
<tr>
<td align="left">Collagen-&#x2160;</td>
<td align="left">66761-1-Ig</td>
<td align="left">proteintech</td>
<td align="left">Mouse</td>
</tr>
<tr>
<td align="left">I&#x3ba;B&#x3b1;</td>
<td align="left">&#x23;4814</td>
<td align="left">cell signaling technology</td>
<td align="left">Mouse</td>
</tr>
<tr>
<td align="left">p38</td>
<td align="left">&#x23;8690</td>
<td align="left">cell signaling technology</td>
<td align="left">Rabbit</td>
</tr>
<tr>
<td align="left">P-p38</td>
<td align="left">&#x23;4511</td>
<td align="left">cell signaling technology</td>
<td align="left">Rabbit</td>
</tr>
<tr>
<td align="left">Arginase-1</td>
<td align="left">ab233548</td>
<td align="left">abcam</td>
<td align="left">Rabbit</td>
</tr>
<tr>
<td align="left">ASK-1</td>
<td align="left">67072-1-Ig</td>
<td align="left">proteintech</td>
<td align="left">Rabbit</td>
</tr>
<tr>
<td align="left">P-ASK-1</td>
<td align="left">28846-1-AP</td>
<td align="left">proteintech</td>
<td align="left">Rabbit</td>
</tr>
<tr>
<td align="left">NF-kB</td>
<td align="left">ab32536</td>
<td align="left">abcam</td>
<td align="left">Rabbit</td>
</tr>
<tr>
<td align="left">P-NF-kB</td>
<td align="left">ab76302</td>
<td align="left">abcam</td>
<td align="left">Rabbit</td>
</tr>
<tr>
<td align="left">iNOS</td>
<td align="left">18985-1-AP</td>
<td align="left">proteintech</td>
<td align="left">Rabbit</td>
</tr>
<tr>
<td align="left">&#x3b2;-Actin</td>
<td align="left">ab8226</td>
<td align="left">abcam</td>
<td align="left">Mouse</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2">
<title>Chemical formula</title>
<p>Chemical structure of AKEX0011</p>
<p>Molecular formula C18H14N5O2F3, mass 389.3&#xa0;g/mol, CAS:1590403-33-0.<inline-graphic xlink:href="fphar-13-1108989-fx1.tif"/>
</p>
</sec>
<sec id="s3">
<title>Polarization</title>
<p>RAW 264.7 cells are a macrophage-like, Abelson leukemia virus-transformed cell line derived from BALB/c mice. This macrophage cell line is commonly used to study phagocytosis, apoptosis, inflammation, as well as M1/M2 polarization. Polarization of M1/M2 phenotype can be determined by the expression of specific M1 (CD80, CD86) and M2 (CD206, CD163) markers detected by flow cytometry. In the <italic>in vitro</italic> experiments of our study, we detected the expression of CD86 and CD163 in RAW264.7 cells of each group by flow cytometry to explore macrophage polarization. Our flow cytometry results confirmed that silica induced polarization of RAW264.7 from M0 macrophages toward certain M1 subtype (F4/80 &#x2b; CD86<sup>&#x2b;</sup>), but have no effect on the polarization towards M2 subtype (F4/80 &#x2b; CD163&#x2b;).</p>
</sec>
</body>
<back>
<sec sec-type="disclaimer" id="s4">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</back>
</article>